Mycophenolate Mofetil for a Flare Child Lupus Nephritis: A Case Reports
DOI:
https://doi.org/10.37275/amcr.v2i2.18Keywords:
Lupus Nephritis, Flare, Mycophenolate Mofetil, Children, Systemic Lupus Erythematosus, CorticosteroidAbstract
Renal involvement is the most common complication of systemic lupus erythematosus (SLE) and is also an important predictor of patient mortality. The incidence of flares is estimated at 65% each year in patients with lupus nephritis. Therapy in lupus nephritis with flare also uses high doses of steroid agents and strong immunosuppression agents. Mycophenolate mofetil (MMF) as an immunosuppression agent tends to favor for flare in lupus nephritis. We describe a patient who had a flare in lupus nephritis that resolved with high-dose steroid and MMF. The combination of immunosuppression agents and high-dose corticosteroids is effective for the control of active diseases. Cyclophosphamide as the steroid-sparing agent was discontinued because of adverse effects as well as hematuria. Partial remission was later achieved and maintained with MMF and corticosteroid after five months of protocol treatment. Thus, MMF while maintaining the steroid dose may induce remission for this case.
Authors
- Gina Puspita1*
- Desy Rusmawatiningtyas2
- Sumadiono3
- 1Faculty of Medicine, Nursing and Health Science, Universitas Muhammadiyah Yogyakarta, Bantul, Indonesia
- 2Division of Pediatric Intensive Emergency, Department of Pediatrics, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
- 3Division of Allergy and Pediatric Immunology, Department of Pediatrics, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
Corresponding author Gina Puspita — gina.puspita@umy.ac.id
Downloads
Published
Issue
Section
License
Authors retain copyright and grant Archives of The Medicine and Case Reports (AMCR) the right of first publication. Published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0). This license permits users to copy, redistribute, and adapt the work for non-commercial purposes, provided that appropriate credit is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license. Copyright in the journal website, logo, layout, and other publisher-owned materials does not transfer copyright in individual articles.
How to Cite
Article Metrics
Views and downloads recorded by this journal. Citation count from OpenAlex.